- Home
- RNXT vs CMBM Comparison
RNXT vs CMBM Comparison
Compare RNXT & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CMBM
- Stock Information
- Founded
- RNXT 2012
- CMBM 2011
- Country
- RNXT United States
- CMBM United States
- Employees
- RNXT N/A
- CMBM N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- RNXT Health Care
- CMBM Technology
- Exchange
- RNXT Nasdaq
- CMBM Nasdaq
- Market Cap
- RNXT 44.6M
- CMBM 18.6M
- IPO Year
- RNXT 2021
- CMBM 2019
- Fundamental
- Price
- RNXT $1.22
- CMBM $0.71
- Analyst Decision
- RNXT Strong Buy
- CMBM Buy
- Analyst Count
- RNXT 2
- CMBM 1
- Target Price
- RNXT $7.50
- CMBM $3.00
- AVG Volume (30 Days)
- RNXT 646.9K
- CMBM 179.7K
- Earning Date
- RNXT 11-12-2025
- CMBM 11-06-2025
- Dividend Yield
- RNXT N/A
- CMBM N/A
- EPS Growth
- RNXT N/A
- CMBM N/A
- EPS
- RNXT N/A
- CMBM N/A
- Revenue
- RNXT $662,000.00
- CMBM $172,215,000.00
- Revenue This Year
- RNXT $2,988.37
- CMBM N/A
- Revenue Next Year
- RNXT $300.60
- CMBM $17.73
- P/E Ratio
- RNXT N/A
- CMBM N/A
- Revenue Growth
- RNXT N/A
- CMBM N/A
- 52 Week Low
- RNXT $0.75
- CMBM $0.23
- 52 Week High
- RNXT $1.69
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- RNXT 55.80
- CMBM 48.64
- Support Level
- RNXT $1.19
- CMBM $0.62
- Resistance Level
- RNXT $1.45
- CMBM $0.78
- Average True Range (ATR)
- RNXT 0.12
- CMBM 0.05
- MACD
- RNXT 0.02
- CMBM 0.00
- Stochastic Oscillator
- RNXT 54.90
- CMBM 49.53
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.